scholarly article | Q13442814 |
P50 | author | Rui Zhang | Q57779235 |
P2093 | author name string | Xiaoli Wang | |
Jie Ma | |||
Yongyong Shi | |||
Meng Liu | |||
Wanqing Liu | |||
Shanshan Wu | |||
Robert K Valenzuela | |||
Congshan Jiang | |||
Fayi Nie | |||
P2860 | cites work | miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells | Q21245271 |
Rethinking schizophrenia | Q22251086 | ||
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes | Q24534395 | ||
Fast and effective prediction of microRNA/target duplexes | Q24537313 | ||
Genome-wide association studies for complex traits: consensus, uncertainty and challenges | Q24550632 | ||
MicroRNAs: target recognition and regulatory functions | Q24609584 | ||
Schizophrenia genetics: new insights from new approaches | Q37483078 | ||
MicroRNAs in psychiatric and neurodevelopmental disorders | Q37730250 | ||
Suggestion of roles for both common and rare risk variants in genome-wide studies of schizophrenia | Q37770196 | ||
Modifications of Small RNAs and Their Associated Proteins | Q37812729 | ||
Experimental validation of candidate schizophrenia gene CALN1 as a target for microRNA-137. | Q38854370 | ||
Two genetic circuits repress the Caenorhabditis elegans heterochronic gene lin-28 after translation initiation | Q43909170 | ||
Validation of schizophrenia-associated genes CSMD1, C10orf26, CACNA1C and TCF4 as miR-137 targets | Q45263643 | ||
Alterations of miR-132 are novel diagnostic biomarkers in peripheral blood of schizophrenia patients | Q47650853 | ||
Evaluating the comparability of gene expression in blood and brain | Q48623627 | ||
MIR137 gene and target gene CACNA1C of miR-137 contribute to schizophrenia susceptibility in Han Chinese. | Q51182260 | ||
Ephrin Bs are essential components of the Reelin pathway to regulate neuronal migration. | Q51874352 | ||
Suggestive evidence for linkage of schizophrenia to markers on chromosome 13 in Caucasian but not Oriental populations. | Q52003328 | ||
Is the EFNB2 locus associated with schizophrenia? Single nucleotide polymorphisms and haplotypes analysis | Q57777772 | ||
Neurodegeneration: export disrupts transport | Q82616710 | ||
MicroRNA dysregulation in psychiatric disease | Q24630375 | ||
MicroRNA miR-137 regulates neuronal maturation by targeting ubiquitin ligase mind bomb-1 | Q24630616 | ||
RNAhybrid: microRNA target prediction easy, fast and flexible | Q24680189 | ||
MicroRNA dysregulation in schizophrenia | Q26861195 | ||
The schizophrenia risk gene product miR-137 alters presynaptic plasticity. | Q27312392 | ||
The functions of animal microRNAs | Q27860621 | ||
Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets | Q27860792 | ||
MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
The lin-4 regulatory RNA controls developmental timing in Caenorhabditis elegans by blocking LIN-14 protein synthesis after the initiation of translation | Q28143010 | ||
Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies | Q28190066 | ||
Genome-wide association analysis identifies 13 new risk loci for schizophrenia | Q28297287 | ||
Comparison of peripheral and central schizophrenia biomarker profiles | Q28484626 | ||
Genome-wide association study identifies a susceptibility locus for schizophrenia in Han Chinese at 11p11.2 | Q28943275 | ||
The widespread impact of mammalian MicroRNAs on mRNA repression and evolution | Q29547173 | ||
Potential Impact of miR-137 and Its Targets in Schizophrenia | Q30454963 | ||
Cross talk between microRNA and epigenetic regulation in adult neurogenesis | Q33788417 | ||
Autosomal recessive lissencephaly with cerebellar hypoplasia is associated with human RELN mutations | Q33845128 | ||
Twin studies of schizophrenia: from bow-and-arrow concordances to star wars Mx and functional genomics | Q33920482 | ||
Experimental validation of candidate schizophrenia gene ZNF804A as target for hsa-miR-137. | Q33924728 | ||
MicroRNA expression aberration as potential peripheral blood biomarkers for schizophrenia | Q33955198 | ||
Modulation of NMDA receptor-dependent calcium influx and gene expression through EphB receptors | Q34110132 | ||
REELIN and schizophrenia: a disease at the interface of the genome and the epigenome | Q34302284 | ||
Further evidence for the association between G72/G30 genes and schizophrenia in two ethnically distinct populations | Q34482854 | ||
Genome-wide association studies: theoretical and practical concerns | Q34555195 | ||
Reelin, lipoprotein receptors and synaptic plasticity | Q34575575 | ||
Plasma processing conditions substantially influence circulating microRNA biomarker levels | Q34769479 | ||
Converging evidence implicates the abnormal microRNA system in schizophrenia | Q35369767 | ||
Meta gene set enrichment analyses link miR-137-regulated pathways with schizophrenia risk | Q35489742 | ||
Rare and common variants: twenty arguments | Q35533255 | ||
Noncoding RNAs in the mammalian central nervous system. | Q36507566 | ||
The neuronal microRNA system | Q36657801 | ||
Common variants on 8p12 and 1q24.2 confer risk of schizophrenia | Q37173580 | ||
P921 | main subject | schizophrenia | Q41112 |
microRNA | Q310899 | ||
P304 | page(s) | 133-142 | |
P577 | publication date | 2016-09-15 | |
P1433 | published in | EBioMedicine | Q24912341 |
P1476 | title | MicroRNA-137 Inhibits EFNB2 Expression Affected by a Genetic Variant and Is Expressed Aberrantly in Peripheral Blood of Schizophrenia Patients | |
P478 | volume | 12 |
Q50015658 | A comprehensive review of the genetic and biological evidence supports a role for MicroRNA-137 in the etiology of schizophrenia. |
Q55314026 | A direct regulatory link between microRNA-137 and SHANK2: implications for neuropsychiatric disorders. |
Q41565842 | Attention: Schizophrenia Risk Gene Product miR-137 Now Targeting EFNB2. |
Q47099376 | Diagnostic value of blood-derived microRNAs for schizophrenia: results of a meta-analysis and validation |
Q92453407 | Epigenetic mechanisms in schizophrenia and other psychotic disorders: a systematic review of empirical human findings |
Q39141707 | High-Throughput Assays to Assess the Functional Impact of Genetic Variants: A Road Towards Genomic-Driven Medicine. |
Q97646203 | OSCC Exosomes Regulate miR-210-3p Targeting EFNA3 to Promote Oral Cancer Angiogenesis through the PI3K/AKT Pathway |
Q90657411 | Rare and common variants analysis of the EMB gene in patients with schizophrenia |
Q33628856 | SNPs in microRNA target sites and their potential role in human disease |
Q92286637 | Transgenic mice overexpressing miR-137 in the brain show schizophrenia-associated behavioral deficits and transcriptome profiles |
Search more.